Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 56% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 4 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 38392.86 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.69 | 1 / 1 |
heart | 100% | 27567.76 | 857 / 861 | 0% | 0 | 0 / 0 |
prostate | 7% | 136.83 | 16 / 245 | 10% | 4.27 | 52 / 502 |
tonsil | 0% | 0 | 0 / 0 | 16% | 3.19 | 7 / 45 |
uterus | 0% | 0 | 0 / 170 | 3% | 0.49 | 12 / 459 |
breast | 1% | 31.66 | 6 / 459 | 1% | 0.38 | 14 / 1118 |
blood vessel | 2% | 109.69 | 25 / 1335 | 0% | 0 | 0 / 0 |
thymus | 1% | 12.64 | 7 / 653 | 1% | 0.35 | 4 / 605 |
liver | 0% | 0 | 0 / 226 | 2% | 0.05 | 7 / 406 |
skin | 0% | 14.45 | 7 / 1809 | 1% | 0.02 | 6 / 472 |
esophagus | 1% | 14.84 | 11 / 1445 | 1% | 0.02 | 1 / 183 |
lung | 1% | 17.16 | 3 / 578 | 1% | 0.07 | 6 / 1155 |
peripheral blood | 1% | 11.87 | 9 / 929 | 0% | 0 | 0 / 0 |
adipose | 1% | 6.27 | 11 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 1.41 | 1 / 328 | 1% | 0.01 | 1 / 178 |
brain | 0% | 0.61 | 3 / 2642 | 1% | 0.01 | 5 / 705 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.02 | 2 / 286 |
adrenal gland | 0% | 3.45 | 1 / 258 | 0% | 0 | 0 / 230 |
intestine | 0% | 0.48 | 1 / 966 | 0% | 0.01 | 1 / 527 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.00 | 1 / 430 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0007015 | Biological process | actin filament organization |
GO_0045214 | Biological process | sarcomere organization |
GO_0051694 | Biological process | pointed-end actin filament capping |
GO_0030041 | Biological process | actin filament polymerization |
GO_0030838 | Biological process | positive regulation of actin filament polymerization |
GO_0006936 | Biological process | muscle contraction |
GO_0045010 | Biological process | actin nucleation |
GO_0030239 | Biological process | myofibril assembly |
GO_0030016 | Cellular component | myofibril |
GO_0031430 | Cellular component | M band |
GO_0030017 | Cellular component | sarcomere |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005865 | Cellular component | striated muscle thin filament |
GO_0005884 | Cellular component | actin filament |
GO_0005523 | Molecular function | tropomyosin binding |
GO_0003785 | Molecular function | actin monomer binding |
GO_0003779 | Molecular function | actin binding |
Gene name | LMOD2 |
Protein name | Leiomodin 2 Leiomodin-2 (Cardiac leiomodin) (C-LMOD) (Leiomodin) |
Synonyms | |
Description | FUNCTION: Mediates nucleation of actin filaments and thereby promotes actin polymerization . Plays a role in the regulation of actin filament length (By similarity). Required for normal sarcomere organization in the heart, and for normal heart function . . |
Accessions | Q6P5Q4 ENST00000458573.3 [Q6P5Q4-1] ENST00000456238.2 C9J8F4 |